200 related articles for article (PubMed ID: 17705263)
1. Viral load in hepatitis B e antigen-negative carriers with normal aminotransferase level.
Liaw YF
Hepatology; 2007 Sep; 46(3):947; author reply 947-9. PubMed ID: 17705263
[No Abstract] [Full Text] [Related]
2. Hepatitis B e antigen-negative patients with persistently normal alanine aminotransferase levels and hepatitis B virus DNA > 2000 IU/mL.
Dai CY; Chuang WL; Huang JF; Yu ML
Hepatology; 2009 Feb; 49(2):704-5; author reply 705-6. PubMed ID: 19177587
[No Abstract] [Full Text] [Related]
3. Hepatitis B.
Mohamadnejad M; Malekzadeh R
N Engl J Med; 2004 Jun; 350(26):2719-20. PubMed ID: 15218580
[No Abstract] [Full Text] [Related]
4. Lack of correlation between hepatitis B surface antigen and hepatitis B virus DNA levels in blood donors.
Allain JP; Sarkodie F; Candotti D; Opare-Sem O
Transfusion; 2005 Jun; 45(6):1039-40. PubMed ID: 15935007
[No Abstract] [Full Text] [Related]
5. Clinical relevance of HBV DNA load in patients with chronic hepatitis B infection.
Madan K; Batra Y; Jha JK; Kumar S; Kalra N; Paul SB; Singh R; Duttagupta S; Panda SK; Acharya SK
Trop Gastroenterol; 2008; 29(2):84-90. PubMed ID: 18972767
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection.
Papatheodoridis GV; Chrysanthos N; Hadziyannis E; Cholongitas E; Manesis EK
J Viral Hepat; 2008 Jun; 15(6):434-41. PubMed ID: 18194171
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of HBe antigen and alanine aminotransferase levels in hepatitis B virus DNA positive patients.
Imtiaz F; Abbas Z; Moatter T
J Coll Physicians Surg Pak; 2005 Feb; 15(2):103-4. PubMed ID: 15730837
[No Abstract] [Full Text] [Related]
8. Specific considerations in the design of hepatitis B virus clinical studies in the far East.
Yuen MF; Lai CL
Methods Mol Med; 2004; 96():457-64. PubMed ID: 14762287
[No Abstract] [Full Text] [Related]
9. Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy.
Tseng TC; Liu CJ; Hsieh SC; Chen PJ; Lai MY; Chen DS; Kao JH
Dig Liver Dis; 2009 Apr; 41(4):322-3. PubMed ID: 18848814
[No Abstract] [Full Text] [Related]
10. Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels.
Tseng TC; Liu CJ; Wang CC; Chen PJ; Lai MY; Chen DS; Kao JH
Antivir Ther; 2009; 14(2):203-10. PubMed ID: 19430095
[TBL] [Abstract][Full Text] [Related]
11. [Prediction of fulminant hepatitis in severe acute hepatitis B].
Michitaka K; Onji M
Nihon Rinsho; 2004 Aug; 62 Suppl 8():269-73. PubMed ID: 15453328
[No Abstract] [Full Text] [Related]
12. Combination of baseline parameters and on-treatment hepatitis B virus DNA levels to start and continue patients with lamivudine therapy.
Yuen MF; Fung J; Seto WK; Wong DK; Yuen JC; Lai CL
Antivir Ther; 2009; 14(5):679-85. PubMed ID: 19704171
[TBL] [Abstract][Full Text] [Related]
13. e-antigen-negative chronic hepatitis B in Bangladesh.
Ahmad N; Alam S; Mustafa G; Adnan AB; Baig RH; Khan M
Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):379-82. PubMed ID: 18693173
[TBL] [Abstract][Full Text] [Related]
14. [Infectivity of hepatitis B].
Gerken G
Dtsch Med Wochenschr; 1996 Apr; 121(14):459. PubMed ID: 8665822
[No Abstract] [Full Text] [Related]
15. Interaction between HIV and hepatitis B.
Bonacini M
AIDS; 1997 Nov; 11(14):1789-90. PubMed ID: 9386822
[No Abstract] [Full Text] [Related]
16. Changing landscape of antiviral resistance management in chronic hepatitis B.
Nguyen T; Locarnini S; Desmond P
J Gastroenterol Hepatol; 2008 Sep; 23(9):1314-7. PubMed ID: 18853991
[No Abstract] [Full Text] [Related]
17. The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression. A prospective cohort study.
Zacharakis G; Koskinas J; Kotsiou S; Tzara F; Vafeiadis N; Papoutselis M; Maltezos E; Sivridis E; Papoutselis K
J Hepatol; 2008 Dec; 49(6):884-91. PubMed ID: 18674840
[TBL] [Abstract][Full Text] [Related]
18. [Progresses in the molecular diagnosis of hepatitis B viral infection].
Panait M; Oprişan G; Codiţă I
Bacteriol Virusol Parazitol Epidemiol; 2008; 53(1):5-12. PubMed ID: 19241991
[No Abstract] [Full Text] [Related]
19. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.
Papatheodoridis GV; Hadziyannis E; Tsochatzis E; Chrysanthos N; Georgiou A; Kafiri G; Manolakopoulos S; Tiniakos DG; Giannousis I; Manesis EK; Archimandritis AJ
Gut; 2008 Apr; 57(4):500-6. PubMed ID: 18025069
[TBL] [Abstract][Full Text] [Related]
20. [Assessment of infectivity of carriers of hepatitis B antigen using viral DNA detection].
Gerlich WH; Heermann KH; Uy A; Zyzik E; Thomssen R
Offentl Gesundheitswes; 1987; 49(8-9):380-4. PubMed ID: 2958735
[No Abstract] [Full Text] [Related]
[Next] [New Search]
